THE FACES OF
INNOVATION
MEETING THE CHALLENGE OF CANCER
The R&D-Based Pharmaceutical Association Committee (RDPAC), representing 47 leading multinational pharmaceutical companies with R&D capabilities, is a committee within the China Association of Enterprises with Foreign Investment (CAEFI).
MEETING THE CHALLENGE OF CANCER
POLICY PILLARS OF PHARMACEUTICAL INNOVATION
FOR A HEALTHIER CHINA
DEEPENING THE DRUG INNOVATION ECOSYSTEM REFORM – A PLAN TO DESIGN AND BUILD CHINA’S CLINICAL RESEARCH SYSTEM